Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Observational Health Data Sciences and Informatics (OHDSI) international community will host a COVID-19 virtual study-a-thon this week (March 26-29) to inform healthcare decision-making in response to the current global pandemic.

Map of COVID-19 cases © Shutterstock
The study-a-thon aims to inform the healthcare response to the COVID-19 pandemic

It is being held in lieu of the cancelled OHDSI European Symposium, which would have taken place in Oxford. Lead organiser Daniel Prieto-Alhambra, Professor of Pharmaco- and Device Epidemiology at NDORMS said: "Our organising committee was hit quite hard when we realised it would be necessary to cancel our long-awaited OHDSI European Symposium, but we quickly realised that our community could come together and make a difference in this global pandemic."

"We are using the time for a COVID-19 virtual study-a-thon that will catalyze a long journey of shared research ahead. Based on the early enthusiasm of our many registrants, I'm optimistic that we can make important progress on the journey and make a meaningful contribution to this international effort."

More than 290 people from 29 different countries have registered for the four-day online event. Alongside the Oxford team are researchers from Erasmus Medical Center, Columbia University, UCLA, Ajou University, Janssen Research and Development, and IQVIA with active participation across government, industry, and academia.

The event is structured to have two main goals: (1) to generate immediate real-world evidence on prioritised questions shared by national governments, public health agencies, health-related institutions, and community members; and (2) to design COVID-19-specific studies that can be validated and available to run when such data is available.

The OHDSI community will initiate its COVID-19 research agenda by designing and executing a series of observational studies across its international network of data captured during clinical practice; these sources include, but are not limited to, electronic health records and administrative claims, the vast majority of which represents data from patient experiences prior to the COVID-19 outbreak. These retrospective analyses will examine the safety of proposed drugs and the effects of various treatments on historical viral diseases, as well as predict outcomes for patients with viral symptoms or complications. Collaborators will also rigorously design studies that will be applied to COVID-19 cases as they are captured in these observational data sources, and new sources are being sought. Patient privacy will be protected in all studies.

All generated real-world evidence will be placed in the public domain to support and inform current public health efforts.

Study collaboration activities will be ongoing throughout the four days, with three daily virtual conferences to update the community on progress throughout the event. Those conferences will be available to all registrants, and daily updates will be shared on OHDSI forums, as well as on the OHDSI Twitter and LinkedIn feeds.

"We have been inspired by the response of our international community as it comes together for this COVID-19 kickoff study-a-thon, which will provide the foundation for a long community research journey on this global pandemic," said George Hripcsak, MD, MS, the Vivian Beaumont Allen Professor and Chair of the Columbia Department of Biomedical Informatics. "At its core, OHDSI is a virtual research community that has built an infrastructure of both high-level analytics and community involvement required to meaningfully impact decision support."

OHDSI is a multi-stakeholder, interdisciplinary collaborative to bring out the value of health data through large-scale analytics. All solutions are open-source. OHDSI has established an international network of researchers and observational health databases with a central coordinating center housed at Columbia University.

You can learn more about OHDSI from this video from the 2019 OHDSI U.S. Symposium, or by checking out www.ohdsi.org.

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Empowering data science for single-cell analysis in Zimbabwe

An innovative computational biology training module was launched in November 2022 at the African Institute of Biomedical Science and Technology (AiBST) in Harare, Zimbabwe, where MSc students were trained in single-cell RNA sequencing data analysis.

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.